Correlation Between Bionomics and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Bionomics and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bionomics and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bionomics Limited and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Bionomics and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bionomics with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bionomics and Quoin Pharmaceuticals.
Diversification Opportunities for Bionomics and Quoin Pharmaceuticals
-0.12 | Correlation Coefficient |
Good diversification
The 3 months correlation between Bionomics and Quoin is -0.12. Overlapping area represents the amount of risk that can be diversified away by holding Bionomics Limited and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Bionomics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bionomics Limited are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Bionomics i.e., Bionomics and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Bionomics and Quoin Pharmaceuticals
If you would invest 75.00 in Quoin Pharmaceuticals Ltd on September 1, 2024 and sell it today you would lose (15.00) from holding Quoin Pharmaceuticals Ltd or give up 20.0% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.79% |
Values | Daily Returns |
Bionomics Limited vs. Quoin Pharmaceuticals Ltd
Performance |
Timeline |
Bionomics Limited |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Quoin Pharmaceuticals |
Bionomics and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Bionomics and Quoin Pharmaceuticals
The main advantage of trading using opposite Bionomics and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bionomics position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.Bionomics vs. BetterLife Pharma | Bionomics vs. Entheon Biomedical Corp | Bionomics vs. Pharmather Holdings | Bionomics vs. Intelgenx Technologs |
Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Neurobo Pharmaceuticals | Quoin Pharmaceuticals vs. Allarity Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stocks Directory Find actively traded stocks across global markets | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets |